• In the summer, a human trial of the vaccine developed by a European consortium begins
  • The pandemic, UN and WHO launch a global initiative to speed up the vaccine
  • Bill Gates: if the Oxford vaccine works I finance it
  • United States, Trump: "The virus will disappear without vaccine, at least 95 thousand dead"
  • Coronavirus, Spallanzani Institute of Rome: vaccine experimentation from July
  • Worldwide fundraising for cures and vaccines is close to 7.5 billion
  • Coronavirus vaccine, storm on Sanofi that would like to give it to the Americans first

Share

May 15, 2020 American President Donald Trump has announced the formation of a team to accelerate the search for the Covid-19 vaccine. Former head of the Glaxo vaccine department, Moncef Slaoui, and General Gustave Perna will be part of it. The first confirmed the president's words, saying that a "vaccine will be ready later this year". The announcement of the tycoon in the White House was met with applause.

"Vaccine or not, we're back. And we're starting the process," said Trump. "Our research is focusing on fourteen types of vaccine that are in clinical trials and are promising," he said at the presentation press conference. "We are making great strides to find the vaccine and the cure for the virus, and we will do it soon, later this year or perhaps earlier. We started working on the vaccine on January 11th even when we knew nothing, there is it's a commitment to produce a vaccine against this new virus. " "There are 450 projects to find cures. We have allocated $ 10 billion for scientific research," he added.

Trump described the Warp Speed ​​operation as "something never seen since World War II". He then denied that the United States wants to do everything on its own, saying that Washington works with all countries. "We work together with many different countries ... there is no ego", he assured.

Moncef Slaoui, the former head of the GlaxoSmithKline vaccine division who was tasked with leading the operation, appeared to share Trump's optimism for a short-term vaccine. The data coming on the tests, he said, "make me feel more than confident about the possibility of being able to distribute a few hundred million doses by the end of 2020".